TAT and infection: Remarkably, as shown in Figure 2, at 20 days after infection 20%–30% of mice infected with HSV1-Tat and HSV1-LacZ at the dose of 108 pfu/mouse were still alive, whereas 100% of mice succumbed to infection with wild-type HSV1 at 106 pfu/mouse.